Fischer Medical Ventures Partners with Bio Angle Vacs to Bring Breakthrough Vaccines to India

Fischer Medical Ventures Limited (formerly known as Fischer Chemic Ltd) has partnered with Bio Angle Vacs Sdn Bhd in Science Technology Marketing to bring their innovative vaccine products into India. This partnership aims to substantially reduce the mortality rate of livestock and aquaculture. Fischer MV, a pioneering force in the healthcare industry, confirmed its investment and collaboration with BAV, a leading Biotechnology company in Malaysia that develops, manufactures, and distributes vaccines worldwide. BAV's flagship innovation, the Spray Technology Vaccine (STVAC), has revolutionized the animal vaccination industry with its advanced recombinant technology and intranasal administration. This technology has shown to enhance protection for small ruminants, especially goats and sheep, against bacterial infections with high mortality rates, reducing mortality rates significantly to below 5%. BAV has secured a total of USD 83 million annual sales contracts from several countries for its range of innovative animal vaccines. Fischer MV, known for its affordable and high-quality medical diagnostic and imaging technologies, is moving into preventative healthcare for livestock and aquaculture with BAV, showing its commitment to improve healthcare through greater food security.